What does impairment of strategic investments mean?

Losses recognized due to the impairment of strategic equity investments that do not have a readily determinable fair market value. This reflects the decline in value of private company holdings or venture-style investments.

Charles River Laboratories CRL Impairment of strategic investments

Discontinued — last reported Q3 '25

Impairment of strategic investments at other companies

Schneider NationalSNDR

$4.9M—

HubSpotHUBS

$913K-42.9%

Align TechnologyALGN

-$4.52M-207%

Philip Morris InternationalPM

$0-100%

CitigroupC

$140M+141%

TwilioTWLO

$80.6M—

Other financials

Income statement

See full

Revenue$995.8M+1.2%

Gross profit$349.0M-3.5%

Operating income$119.9M+60.6%

Net income-$14.8M-158%

EPS (diluted)-$0.30-160%

Balance sheet

See full

Cash & equivalents$198.2M-14.5%

Total debt$3.1B+1.9%

Total equity$2.9B-7.9%

Total assets$7.7B+2.0%

Cash flow

See full

Operating cash flow$41.1M-76.1%

CapEx$55.9M-5.8%

Free cash flow-$14.8M-113%

Valuation

See full

Market cap$8.91B+10.3%

Enterprise value$11.79B+8.5%

P/S2.2×+0.2×

Profitability

See full

Gross margin84.7%—

Operating margin13%-2.4pp

Net margin-4.6%—

FCF margin9.7%-4.3pp

Returns & leverage

See full

Return on equity-6%—

Debt / equity1×+0.1×

Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount.

The official record: Charles River Laboratories’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's impairment of strategic investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Charles River Laboratories's impairment of strategic investments?: Charles River Laboratories (CRL) reported impairment of strategic investments of $17.4M in Q3 2025.
How has Charles River Laboratories's impairment of strategic investments changed year-over-year?: Charles River Laboratories's impairment of strategic investments increased by 332.3% year-over-year, from $4.03M to $17.4M.
What does impairment of strategic investments mean?: Losses recognized due to the impairment of strategic equity investments that do not have a readily determinable fair market value. This reflects the decline in value of private company holdings or venture-style investments.